by HealthDay Reporter | May 16, 2024
Model predicts smoldering multiple myeloma or worse among patients with monoclonal gammopathy of undetermined significance. A recently developed multivariable model can accurately predict smoldering multiple myeloma (SMM) or worse in persons with...
by HealthDay Reporter | May 10, 2024
Patients with stromal-predominant tumors had the youngest age at diagnosis compared with other histologic subtypes. Bilateral Wilms tumors (BWTs) that increase in size during neoadjuvant chemotherapy, especially in younger patients, are most often...
by HealthDay Reporter | May 9, 2024
Etidronate seems to slow progression of further vascular calcification. For patients with arterial calcification due to deficiency of CD73 (ACDC), etidronate may slow progression of vascular calcification in the lower extremities, according to a study...
by HealthDay Reporter | May 7, 2024
Association strongest for B-cell precursor acute lymphoblastic leukemia. Exclusive breastfeeding duration of at least three months may decrease the risk for childhood hematologic cancers, according to a study published online March 26 in JAMA Network...
by HealthDay Reporter | May 6, 2024
Following disappointing trial results, the maker of a controversial ALS drug said it is pulling the medication off the market. In a statement issued Thursday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a large follow-up study,...
